Article Publish Status: FREE
Abstract Title:

Synergy between parthenolide and arsenic trioxide in adult T-cell leukemia/lymphoma cells.

Abstract Source:

Iran J Basic Med Sci. 2020 May ;23(5):616-622. PMID: 32742599

Abstract Author(s):

Hamideh Kouhpaikar, Mohammad Hadi Sadeghian, Houshang Rafatpanah, Mohaddeseh Kazemi, Mehrdad Iranshahi, Zahra Delbari, Faezeh Khodadadi, Hossein Ayatollahi, Fatemeh B Rassouli

Article Affiliation:

Hamideh Kouhpaikar


Objectives: Adult T-cell leukemia/lymphoma (ATLL) is an aggressive lymphoid malignancy with low survival rate and distinct geographical distribution. In search for novel chemotherapeutics against ATLL, we investigated the combinatorial effects of parthenolide, a sesquiterpene lactone with valuable pharmaceutical activities, and arsenic trioxide (ATO).

Materials and Methods: MT2 cells, an ATLL cell line, were treated with increasing concentrations of parthenolide (1.25, 2.5, and 5μg/ml) and ATO (2, 4, 8, and 16 µM) to determine their IC. Then, cells were treated with a combination of sub-ICconcentrations of parthenolide (1μg/ml) and ATO (2 µM) for 72 hr. Cell viability and cell cycle changes were assessed by Alamar blue and PI staining, respectively. To understand the mechanisms responsible for observed effects, expression of, andwere investigated by real-time PCR.

Results: Assessment of cell viability indicated that parthenolide significantly increased the toxicity of ATO, as confirmed by accumulation of MT2 cells in the sub G1 phase of the cell cycle. Moreover, molecular analysis revealed significant down-regulation of, andupon combinatorial administration of parthenolide and ATO in comparison with relevant controls.

Conclusion: Taken together, present results showed that parthenolide significantly enhanced the toxicity of ATO in MT2 cells. Therefore, the future possible clinical impact of our study could be combinatorial use of parthenolide and ATO as a novel and more effective approach for ATLL.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2023 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.